| Title |
Treatment of Tuberculosis in a Region with High Drug Resistance: Outcomes, Drug Resistance Amplification and Re-Infection
|
|---|---|
| Published in |
PLOS ONE, August 2011
|
| DOI | 10.1371/journal.pone.0023081 |
| Pubmed ID | |
| Authors |
Maryline Bonnet, Manuela Pardini, Francesca Meacci, Germano Orrù, Hasan Yesilkaya, Thierry Jarosz, Peter W. Andrew, Mike Barer, Francesco Checchi, Heinz Rinder, Graziella Orefici, Sabine Rüsch-Gerdes, Lanfranco Fattorini, Marco Rinaldo Oggioni, Juliet Melzer, Stefan Niemann, Francis Varaine |
| Abstract |
Emerging antituberculosis drug resistance is a serious threat for tuberculosis (TB) control, especially in Eastern European countries. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 118 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 2 | 2% |
| Ghana | 1 | <1% |
| Switzerland | 1 | <1% |
| India | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 112 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 23 | 19% |
| Researcher | 18 | 15% |
| Student > Bachelor | 15 | 13% |
| Other | 11 | 9% |
| Student > Ph. D. Student | 10 | 8% |
| Other | 25 | 21% |
| Unknown | 16 | 14% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 46 | 39% |
| Agricultural and Biological Sciences | 15 | 13% |
| Biochemistry, Genetics and Molecular Biology | 7 | 6% |
| Nursing and Health Professions | 7 | 6% |
| Immunology and Microbiology | 6 | 5% |
| Other | 11 | 9% |
| Unknown | 26 | 22% |